Evolus EOLS Earnings Call Transcripts

NASDAQ EOLS
$6.81 -0.17 (-2.44%)
At close: Nov 10, 2026 · 4:00 PM EST
8 earnings calls on file for Evolus, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Evolus Q3 2026 Earnings Call

Nov 4, 2026 5,069 words · 22 min read
  • David MoatazediPresident and Chief Executive Officer
  • Rui AvelarChief Medical Officer and Head of R&D
  • Tatjana MitchellChief Financial Officer
  • Nareg SagherianVice President and Head of Global Investor Relations and Corporate Communications
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Evolus Earnings Call Transcripts

Calls8
LatestNov 4, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2020

Fiscal 2019

All 8 Evolus transcripts Register to get access to Evolus’s earnings call transcripts.